Cargando…
Lysophospholipids: A Potential Drug Candidates for Neurodegenerative Disorders
Neurodegenerative diseases (NDs) commonly present misfolded and aggregated proteins. Considerable research has been performed to unearth the molecular processes underpinning this pathological aggregation and develop therapeutic strategies targeting NDs. Fibrillary deposits of α-synuclein (α-Syn), a...
Autores principales: | Karaki, Tatsuya, Haniu, Hisao, Matsuda, Yoshikazu, Tsukahara, Tamotsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775253/ https://www.ncbi.nlm.nih.gov/pubmed/36551882 http://dx.doi.org/10.3390/biomedicines10123126 |
Ejemplares similares
-
Lysophospholipid-Related Diseases and PPARγ Signaling Pathway
por: Tsukahara, Tamotsu, et al.
Publicado: (2017) -
Porcine liver decomposition product-derived lysophospholipids promote microglial activation in vitro
por: Tsukahara, Tamotsu, et al.
Publicado: (2020) -
Therapeutic Potential of Porcine Liver Decomposition Product: New Insights and Perspectives for Microglia-Mediated Neuroinflammation in Neurodegenerative Diseases
por: Tsukahara, Tamotsu, et al.
Publicado: (2020) -
PTB-Associated Splicing Factor (PSF) Is a PPARγ-Binding Protein and Growth Regulator of Colon Cancer Cells
por: Tsukahara, Tamotsu, et al.
Publicado: (2013) -
PSF Knockdown Enhances Apoptosis via Downregulation of LC3B in Human Colon Cancer Cells
por: Tsukahara, Tamotsu, et al.
Publicado: (2013)